Abella, Michael B.
HRN: 23-74-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/05/2026
06/12/2026
PO
4.5ml
Q8hrs
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes